Xuan Cui

537 total citations
24 papers, 379 citations indexed

About

Xuan Cui is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xuan Cui has authored 24 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Ophthalmology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xuan Cui's work include Retinal Development and Disorders (15 papers), Retinal Diseases and Treatments (11 papers) and Photoreceptor and optogenetics research (7 papers). Xuan Cui is often cited by papers focused on Retinal Development and Disorders (15 papers), Retinal Diseases and Treatments (11 papers) and Photoreceptor and optogenetics research (7 papers). Xuan Cui collaborates with scholars based in United States, China and Israel. Xuan Cui's co-authors include Stephen H. Tsang, Karen Sophia Park, Ruben Jauregui, Christine L. Xu, Yi‐Ting Tsai, Wen-Hsuan Wu, Chyuan‐Sheng Lin, Xiaorong Li, Sally Justus and Yifeng Ke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Xuan Cui

22 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuan Cui United States 12 266 125 86 72 37 24 379
Tomomi Metoki Japan 13 236 0.9× 207 1.7× 70 0.8× 82 1.1× 28 0.8× 22 430
Janmeet S. Saini United States 8 382 1.4× 170 1.4× 105 1.2× 56 0.8× 11 0.3× 9 476
Michael Nahmou United States 11 217 0.8× 58 0.5× 67 0.8× 86 1.2× 18 0.5× 17 301
Valeria Chichagova United Kingdom 12 307 1.2× 92 0.7× 63 0.7× 92 1.3× 13 0.4× 15 374
Mark Basche United Kingdom 9 278 1.0× 94 0.8× 58 0.7× 97 1.3× 11 0.3× 10 326
Sally Justus United States 13 536 2.0× 207 1.7× 55 0.6× 138 1.9× 29 0.8× 18 596
Wen-Hsuan Wu United States 9 550 2.1× 177 1.4× 75 0.9× 152 2.1× 18 0.5× 18 617
Bhubanananda Sahu United States 13 276 1.0× 122 1.0× 36 0.4× 60 0.8× 11 0.3× 21 344
Qinzhu Huang China 11 176 0.7× 132 1.1× 105 1.2× 19 0.3× 29 0.8× 15 336
Marina França Dias Brazil 3 290 1.1× 125 1.0× 34 0.4× 77 1.1× 10 0.3× 6 337

Countries citing papers authored by Xuan Cui

Since Specialization
Citations

This map shows the geographic impact of Xuan Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Cui more than expected).

Fields of papers citing papers by Xuan Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Cui. The network helps show where Xuan Cui may publish in the future.

Co-authorship network of co-authors of Xuan Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Cui. A scholar is included among the top collaborators of Xuan Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Cui. Xuan Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ping, et al.. (2026). MDP25‐VDAC3 Complex Orchestrates Actin Remodeling and Mitochondrial Dynamics to Modulate Innate Immunity in Arabidopsis. Advanced Science. 13(14). e13442–e13442. 1 indexed citations
2.
Xu, Ying, Nan Li, Li Xu, et al.. (2025). Integrated analysis strategies reveal the pharmacodynamic substances and action mechanisms of Huangqi San in the treatment of Alzheimer’s disease. Journal of Pharmaceutical and Biomedical Analysis. 270. 117251–117251.
3.
Cui, Xuan, Daniel T. Hass, Peter M. J. Quinn, et al.. (2025). Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa. Journal of Clinical Investigation. 135(7). 2 indexed citations
4.
Wang, Feng, et al.. (2024). Diffusion tensor imaging in cerebral small vessel disease applications: opportunities and challenges. Frontiers in Neuroscience. 18. 1473462–1473462. 2 indexed citations
5.
Cui, Xuan, Wen-Hsuan Wu, Chyuan‐Sheng Lin, et al.. (2024). CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa. Cell Reports Medicine. 5(4). 101459–101459. 8 indexed citations
6.
Cui, Xuan, Minxia Zou, & Jiejie Li. (2023). Basally distributed actin array drives embryonic hypocotyl elongation during the seed‐to‐seedling transition in Arabidopsis. New Phytologist. 240(1). 191–206. 7 indexed citations
7.
Liu, Pei‐Kang, Yao Li, Peter M. J. Quinn, et al.. (2023). HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy. EMBO Molecular Medicine. 15(2). e16525–e16525. 15 indexed citations
9.
Wu, Wen-Hsuan, Yi‐Ting Tsai, I‐Wen Huang, et al.. (2022). CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa. Molecular Therapy. 30(4). 1407–1420. 23 indexed citations
10.
Cui, Xuan, et al.. (2022). Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent. Methods in molecular biology. 2560. 229–232.
11.
Cui, Xuan, Hye Jin Kim, José Ronaldo Lima de Carvalho, et al.. (2022). Long-term vitamin A supplementation in a preclinical mouse model forRhoD190N-associated retinitis pigmentosa. Human Molecular Genetics. 31(14). 2438–2451. 10 indexed citations
12.
Zhang, Ethan, Sarah R. Levi, Xuan Cui, et al.. (2020). PKM2 ablation enhanced retinal function and survival in a preclinical model of retinitis pigmentosa. Mammalian Genome. 31(3-4). 77–85. 12 indexed citations
13.
Chang, Ya‐Ju, Christine L. Xu, Xuan Cui, et al.. (2019). CRISPR Base Editing in Induced Pluripotent Stem Cells. Methods in molecular biology. 2045. 337–346. 12 indexed citations
14.
Jauregui, Ruben, et al.. (2019). Multimodal structural disease progression of retinitis pigmentosa according to mode of inheritance. Scientific Reports. 9(1). 10712–10712. 29 indexed citations
15.
Sancho-Pellúz, Javier, Xuan Cui, Winston Lee, et al.. (2019). Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a RhoD190N mutation. Cellular and Molecular Life Sciences. 76(18). 3657–3665. 6 indexed citations
16.
Zhang, Lijuan, Xuan Cui, Ruben Jauregui, et al.. (2018). Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa. Molecular Therapy. 26(8). 1953–1964. 18 indexed citations
17.
Park, Karen Sophia, Christine L. Xu, Xuan Cui, & Stephen H. Tsang. (2018). Reprogramming the metabolome rescues retinal degeneration. Cellular and Molecular Life Sciences. 75(9). 1559–1566. 19 indexed citations
18.
Tsai, Yi‐Ting, Wen-Hsuan Wu, Christine L. Xu, et al.. (2018). Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa. Ophthalmology. 125(9). 1421–1430. 95 indexed citations
19.
Cui, Xuan, Ruben Jauregui, Karen Sophia Park, & Stephen H. Tsang. (2018). Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy. Ophthalmic Genetics. 39(4). 512–516. 13 indexed citations
20.
Ke, Yifeng, Xuan Cui, Yang Liu, et al.. (2015). Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats. PLoS ONE. 10(3). e0119725–e0119725. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026